Sources, fields and coverage
Dossier displays selected fields from public FDA, EMA and ClinicalTrials.gov records. Each record links to its source and identifies the fields imported. Text on this site does not add a medical interpretation.
Current indexed records
Counts from the latest completed index update: 2026-10-31T01:10:49.094799+00:00.
- 660,264 unique identified source studies or records in the source-only index
- 664,165 imported snapshots; a study can have multiple record updates
- ClinicalTrials.gov: 580,006 records
- FDA (openFDA): 73,706 records
- EMA (European Medicines Agency): 6,552 records
- 582,101 records contain at least one imported condition or therapeutic-area term
- 126 records include imported intervention fields
- 0 records include explicit indication wording in the imported fields
- 0 records include an explicit source-backed drug-condition pair
Unique studies are grouped by source and ClinicalTrials.gov study ID; other source records use their feed item ID. Snapshot counts include imported updates. Field counts refer to unique identified records in this index only; they do not measure evidence strength or completeness.
How source fields are kept distinct
- ClinicalTrials.gov conditions, intervention names, phase and overall status are record-level fields. A condition and an intervention appearing in one study are not presented as proof that every pair is a treatment, that the study had a result, or that an intervention is approved.
- FDA application and submission records show their recorded application, submission status and drug names. If the imported record has no indication wording, the page says so.
- EMA therapeutic-area terms are indexing terms. They are not presented as the authorised indication. If the imported fields do not contain indication wording, the page says so.
- Names and terms keep the source spelling and qualifiers. Punctuation and case may be normalized for browsing; Dossier does not infer synonym equivalence or broaden a term.
Dates and record status
Dates are shown with their source-field names where available. A record update date is not a trial-results date. An event is labelled results posted only when the source record identifies the results-posted subtype and includes a results date; that label does not imply a particular result. Trial phases and statuses remain attached to their individual study records; they are not rolled up into a treatment stage or approval likelihood.
An FDA application event is not the first approval of a molecule. Earliest indexed approval events, first-molecule approval and later supplements remain distinct. Unknown dates remain unknown. Missing records in this index do not establish that no approval, study or indication exists elsewhere.
Limits
The index contains selected adapter fields, not necessarily the complete original record. Current imported feeds do not provide complete intervention data for all trials or explicit approved-indication wording for every agency record. A missing imported field is shown as not stated in this record view. Follow the source link to inspect the complete record and its context.
Original HTTP retrieval timestamps were not retained for older imported snapshots. Where shown, “first stored” is not the same as the upstream retrieval time. Newer source retrieval and official enrichment timestamps identify their respective operations; they do not mean the source was independently checked for later changes.
Free browsing includes the available source fields and official source links. Plus provides personal organization tools and removes ads. Prices for new subscribers are US $1.99/month or exactly US $19/year through Google Play; localized price and billing period appear in the store before purchase.
Questions about sources: support@catalystwire.org